why choose us

Clinical Trials Search

Showing 15,240 of 132,963 result(s)
Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

Status: COMPLETED

Condition: Myeloid Malignancies

Interventions: KT-253 will be administered intravenously per the defined protocol frequency and dose level.

Date: 2023-02-10

The Rehabilitation of Atrophic Jaws Using Short Implants With Different Surface Characteristics

Status: COMPLETED

Condition: Peri-Implantation Loss

Interventions: The intervention will consist of placement of two types of short implants (one with traditional machined collar and one with anodized collar).
Af

Date: 2023-02-10

Observational Study of Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

Status: Completed

Condition: Chronic Lymphocytic Leukemia (CLL)

Interventions:

Date: 2023-02-10

CT Evaluation of Carotid Plaque Components

Status: Completed

Condition: Carotid Plaque

Interventions:

Date: 2023-02-10

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

Status: Completed

Condition: Type 2 Diabetes

Interventions: In addition to receiving routine care, participants will receive GEM, a structured, self-directed, and personalized program that will allow participan

Date: 2023-02-10

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC;BPS

Status: Completed

Condition: Interstitial Cystitis

Interventions: VNX001 (alkalinized lidocaine HCl and heparin sodium)

Date: 2023-02-10

PCMS Task After Moderate-to-severe Stroke

Status: Completed

Condition: Stroke

Interventions: 120 pairs of TMS and PNS volleys will be administered during electromyography-triggered functional electrical stimulation (FES)-assisted task-specific

Date: 2023-02-10

Therapy Program for Academic Skills in Children With Intellectual Disability

Status: COMPLETED

Condition: Intellectual Disability, Mild

Interventions: A combined program based on physical and occupational therapy techniques within a play context

Date: 2023-02-10

To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone

Status: NOT_YET_RECRUITING

Condition: Submucous Leiomyoma of Uterus

Interventions: Patients with fibroid remained will be enrolled and divided into three groups.
one group wii be administrated with Zoladex (3.60mg;28 days)

Date: 2023-02-10